Neuroprotective Strategies for Parkinson's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|2|3|309-322

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.2, Iss.3, 2004-01, pp. : 309-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possible Neuroprotective Strategies for Huntington's Disease

By  

Current Neuropharmacology, Vol. 2, Iss. 3, 2004-01 ,pp. : 331-342

Bentham Science Publishers

Access to resources Recommend Favorite

Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 383-403

Bentham Science Publishers

Access to resources Recommend Favorite

Current Evidence for Neuroprotective Effects of Nicotine and Caffeine Against Parkinson's Disease

By Ross G.W.  

Drugs & Aging, Vol. 18, Iss. 11, 2001-01 ,pp. : 797-806

Adis International

Access to resources Recommend Favorite

Are Dopamine Receptor Agonists Neuroprotective in Parkinson's Disease?

By Le W-D.   Jankovic J.  

Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. : 389-396

Adis International

Access to resources Recommend Favorite